Mark A. Berman - Net Worth and Insider Trading
Mark A. Berman Net Worth
The estimated net worth of Mark A. Berman is at least $3,882 dollars as of 2024-04-28. Mark A. Berman is the Chief Medical Officer of Better Therapeutics Inc and owns about 388,191 shares of Better Therapeutics Inc (BTTX) stock worth over $3,882. Details can be seen in Mark A. Berman's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Mark A. Berman has not made any transactions after 2023-07-27 and currently still holds the listed stock(s).
Transaction Summary of Mark A. Berman
Mark A. Berman Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Mark A. Berman owns 2 companies in total, including Better Therapeutics Inc (BTTX) , and Mountain Crest Acquisition Corp II (MCADU) .
Click here to see the complete history of Mark A. Berman’s form 4 insider trades.
Insider Ownership Summary of Mark A. Berman
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| BTTX | Better Therapeutics Inc | 2023-07-27 | Chief Medical Officer |
| MCADU | Mountain Crest Acquisition Corp II | 2021-10-28 | Chief Medical Officer |
Mark A. Berman Latest Holdings Summary
Mark A. Berman currently owns a total of 1 stock. Mark A. Berman owns 388,191 shares of Better Therapeutics Inc (BTTX) as of July 27, 2023, with a value of $3,882.
Latest Holdings of Mark A. Berman
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| BTTX | Better Therapeutics Inc | 2023-07-27 | 388,191 | 0.01 | 3,882 |
Holding Weightings of Mark A. Berman
Mark A. Berman Form 4 Trading Tracker
According to the SEC Form 4 filings, Mark A. Berman has made a total of 1 transactions in Better Therapeutics Inc (BTTX) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Better Therapeutics Inc is the acquisition of 54,802 shares on July 27, 2023, which cost Mark A. Berman around $40,006.
Insider Trading History of Mark A. Berman
- 1
Mark A. Berman Trading Performance
GuruFocus tracks the stock performance after each of Mark A. Berman's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Mark A. Berman is -70.43%. GuruFocus also compares Mark A. Berman's trading performance to market benchmark return within the same time period. The performance of stocks bought by Mark A. Berman within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Mark A. Berman's insider trading performs compared to the benchmark.
Performance of Mark A. Berman
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 3.24 | -70.43 | -69.91 | |||
| Relative Return to S&P 500(%) | 6.14 | -61.17 | -77.7 |
Mark A. Berman Ownership Network
Ownership Network List of Mark A. Berman
Ownership Network Relation of Mark A. Berman
Mark A. Berman Owned Company Details
What does Better Therapeutics Inc do?
Who are the key executives at Better Therapeutics Inc?
Mark A. Berman is the Chief Medical Officer of Better Therapeutics Inc. Other key executives at Better Therapeutics Inc include director & See Remarks Frank Karbe , director & 10 percent owner & See Remarks David P Perry , and 10 percent owner Georgianna Maule-ffinch 2015 Trust .
Better Therapeutics Inc (BTTX) Insider Trades Summary
Over the past 18 months, Mark A. Berman made 1 insider transaction in Better Therapeutics Inc (BTTX) with a net purchase of 54,802. Other recent insider transactions involving Better Therapeutics Inc (BTTX) include a net purchase of 6,202,742 shares made by David P Perry , a net purchase of 988,055 shares made by Geoffrey M. Parker , and a net purchase of 577,040 shares made by Andrew J. Armanino .
In summary, during the past 3 months, insiders sold 0 shares of Better Therapeutics Inc (BTTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Better Therapeutics Inc (BTTX) were sold and 8,236,919 shares were bought by its insiders, resulting in a net purchase of 8,236,919 shares.
Better Therapeutics Inc (BTTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Better Therapeutics Inc Insider Transactions
Mark A. Berman Mailing Address
Above is the net worth, insider trading, and ownership report for Mark A. Berman. You might contact Mark A. Berman via mailing address: 548 Market Street, #49404, San Francisco Ca 94104.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
